US EditionPublished • loading... • Updated
White House to Announce Drug Pricing Deal with Regeneron
Regeneron will cut Medicaid prices and list Praluent on TrumpRx, while committing nearly $10 billion to U.S. production, Reuters reported.
- President Donald Trump will announce a deal with Regeneron Pharmaceuticals on Thursday to lower drug costs, reducing Medicaid prices and offering the cholesterol drug Praluent for $225 on The White House's discounted website TrumpRx.
- Regeneron is the final company of 17 major pharmaceutical firms to sign such an accord, following letters Trump sent Last July aimed at aligning United States drug costs with those in other developed nations.
- As part of the pact, Regeneron committed nearly $10 billion to bring pharmaceutical production to the United States and received approval for its gene therapy Otarmeni, which will be provided for free to Patients.
- Health Secretary Robert urged Congress to codify these deals into law; when pressed by lawmakers for contract details, Kennedy said his team would disclose information excluding proprietary trade secrets.
- Regeneron shares rose more than 2% in morning trade as the administration effort provides economic relief ahead of November's midterm elections, addressing Americans' concerns about high healthcare costs.
Insights by Ground AI
57 Articles
57 Articles
Trump unveils deal with Regeneron to lower its drug prices for Medicaid
President Donald Trump on Thursday announced a deal with drugmaker Regeneron to lower the cost of its pharmaceutical products as part of the White House's signature drug pricing initiative.
·Washington, United States
Read Full Article
‘Even the fake news has to be impressed’: Trump announces new plan to cut prices of pharmaceuticals * WorldNetDaily * by Bob Unruh
Source link President Donald Trump on Thursday announced a new program to cut the costs of pharmaceuticals for consumers, a problem he repeatedly has worked to address while in the White House. The new plan, according to a report from legacy wire service AP, is that drugmaker Regeneron will lower the cost of its products
Coverage Details
Total News Sources57
Leaning Left18Leaning Right15Center21Last UpdatedBias Distribution39% Center
Bias Distribution
- 39% of the sources are Center
39% Center
L 33%
C 39%
R 28%
Factuality
To view factuality data please Upgrade to Premium
